Please check your internet connection and try again.
# Isoxsuprine Hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator and smooth muscle relaxant. Its exact mechanism of action is not fully understood, but it is thought to act directly on vascular smooth muscle and uterine muscle.
## Primary Indications
* Treatment of peripheral vascular disease (e.g., intermittent claudication, Raynaud's phenomenon).
* Treatment of threatened premature labor (tocolytic).
## Adult Dosing
* **Peripheral vascular disease:** 10 mg to 20 mg orally three to four times daily.
* **Threatened premature labor:** 10 mg orally every hour for up to 4 hours, then 10 mg to 20 mg orally every 4 to 6 hours as needed. Oral administration is typically initiated after IV tocolysis has stabilized the patient.
## Pediatric Dosing
There is no established pediatric dosing for isoxsuprine hydrochloride.
## Dose Adjustments
No specific dose adjustments are routinely recommended for hepatic or renal impairment. However, caution and close monitoring are advised, especially in patients with compromised organ function.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Should not be used in the immediate postpartum period.
* Avoid in patients with known cardiac arrhythmias.
## Adverse Effects
Common adverse effects include:
* Hypotension (especially with rapid titration or higher doses)
* Tachycardia
* Nausea
* Vomiting
* Dizziness
* Weakness
* Gastrointestinal upset
* Flushing
Less common but serious adverse effects include:
* Pulmonary edema (especially in pregnant patients)
* Cardiac arrhythmias
## Key Drug Interactions
* **Antihypertensives:** May potentiate hypotensive effects. Closely monitor blood pressure.
* **Other vasodilators:** Additive vasodilatory effects may lead to increased hypotension.
## Monitoring
* Blood pressure: Monitor for hypotension, especially after initiation or dose changes.
* Heart rate: Monitor for tachycardia.
* Signs and symptoms of peripheral ischemia (for peripheral vascular disease indication).
* Uterine activity and fetal well-being (for tocolysis indication).
## Clinical Pearls
* Effectiveness in peripheral vascular disease is controversial and not well-supported by high-quality evidence.
* When used as a tocolytic, it is generally reserved for oral maintenance after initial IV therapy.
* Administer with food to minimize gastrointestinal upset.
* Patient education regarding potential side effects, especially dizziness and hypotension, is crucial.
***
*Please verify current prescribing information and local protocols before initiating or adjusting therapy.*
